Application for this study are now closed
Browse our other trials that are currently recruiting
C04723 COPD (Chronic Obstructive Pulmonary Disease) Trial
CMAX Clinical Research in Partnership with our GP Clinic Network
CMAX require the help of adults, aged 35-80, to trial a potential new Chronic Obstructive Pulmonary Disease (COPD) treatment in an upcoming Phase 1 clinical trial.
The trial requires participants to stay at the Adelaide based CMAX facility for 11 consecutive nights and receive 1 follow up phone call. All eligible participants are paid for their time.
Eligibility requirements
- Age: Age 35-80 (inclusive)
- Sex: Male and female
- BMI: ≥ 18.0 kg/m2 and ≤ 35.0 kg/m2 and weigh ≥ 50 kg for males and ≥ 45 kg for females at screening
- Medication: On stable maintenance COPD medication with no dose adjustments for ≥6 weeks prior to Screening
- Medical History: Documented diagnosis of COPD and moderate airflow limitation
Overnight Stays
- 11
Payment/Remuneration
- If accepted into the study, as payment for your time, out of pocket expenses and inconvenience experienced, you will receive $6,320 for completing the study.